Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Dr Huhn and Dr Mussini

Source: CCO Independent Conference Coverage of IDWeek 2022: Clinical Impact of New COVID-19 Data*

October 19-23, 2022; Washington, DC

Listen to expert insights on updates and new COVID-19 data from IDWeek 2022, including data on vaccines, risk factors and risk stratification, diagnostics, therapeutics, treatment of patients with immunocompromise, and long COVID.

Gregory Huhn, MD, MPHTM

Cristina Mussini, MD

Released: November 8, 2022

Information on this Educational Activity

Faculty

Gregory Huhn, MD, MPHTM

Professor of Medicine
Department of Infectious Diseases
Rush University Medical Center
Interim Chief
Division of Infectious Diseases
Cook County Health
Chicago, Illinois

Gregory Huhn, MD, MPHTM: consultant/advisor/speaker: Gilead Sciences, Integritas, Janssen, Lilly, Merck, ViiV; researcher: Gilead Sciences, Janssen, Lilly, ViiV.

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases
Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Cristina Mussini, MD: consultant/advisor/speaker: AbbVie, Angelini, Gilead Sciences, GlaxoSmithKline, Janssen, MSD, Pfizer, Roche, ViiV; researcher: Gilead Sciences, Janssen, MSD, ViiV.

Program Medium

This program has been made available online.

Welcome to the CCO Site

Key COVID-19 Studies Influencing My Practice Following IDWeek 2022—Dr Huhn and Dr Mussini

Information on this Educational Activity

Faculty

Program Medium

Leaving the CCO site